Search results
Pfizer to test third dose of COVID-19 vaccine in children
AOL· 5 hours agoThe decision was made after an analysis showed the two-dose vaccine generated an immune response in...
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 14 hours agoA young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy...
Pfizer reports patient death in Duchenne gene therapy study
Reuters via Yahoo News· 14 hours ago(Reuters) -A young patient died due to cardiac arrest after receiving Pfizer's experimental gene...
AstraZeneca Withdraws Covid Vaccine As Demand Dives
International Business Times· 9 minutes agoAnglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing "commercial reasons" following a slump ...
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 11 hours agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
AstraZeneca: What are the rare side effects of the Covid jab?
The Independent via Yahoo News· 4 minutes agoHowever, the government largely stopped using the jab and it was replaced in the UK with Pfizer and...
Market Today: Pfizer Pauses Gene Therapy Trial After Patient Dea
Guru Focus· 12 hours agoThe stock market exhibited mixed results at the close today. The Nasdaq Composite edged down by...
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 7 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 7 days agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
